Julian N. Robinson, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obstetric Labor Complications | 8 | 2022 | 244 | 2.980 |
Why?
|
| Delivery, Obstetric | 17 | 2022 | 954 | 2.750 |
Why?
|
| Cesarean Section | 18 | 2022 | 1425 | 2.550 |
Why?
|
| Labor Stage, Second | 3 | 2022 | 46 | 2.030 |
Why?
|
| Labor Presentation | 5 | 2018 | 56 | 1.490 |
Why?
|
| Maternal Health Services | 5 | 2021 | 472 | 1.250 |
Why?
|
| Obstetrics | 6 | 2021 | 681 | 1.070 |
Why?
|
| Parturition | 3 | 2019 | 455 | 1.030 |
Why?
|
| Pregnancy | 57 | 2023 | 30255 | 1.030 |
Why?
|
| Pregnancy Complications | 5 | 2020 | 2973 | 0.960 |
Why?
|
| Pregnancy Outcome | 7 | 2021 | 2972 | 0.760 |
Why?
|
| Labor, Induced | 3 | 2021 | 156 | 0.710 |
Why?
|
| Perineum | 3 | 2018 | 212 | 0.680 |
Why?
|
| Gestational Age | 11 | 2020 | 3621 | 0.670 |
Why?
|
| Home Childbirth | 1 | 2019 | 55 | 0.630 |
Why?
|
| Attitude of Health Personnel | 5 | 2021 | 3929 | 0.590 |
Why?
|
| Postpartum Period | 5 | 2023 | 1197 | 0.570 |
Why?
|
| Labor, Obstetric | 2 | 2018 | 323 | 0.560 |
Why?
|
| Perinatal Care | 1 | 2019 | 245 | 0.540 |
Why?
|
| Hyponatremia | 1 | 2019 | 279 | 0.540 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2016 | 24 | 0.540 |
Why?
|
| Rehydration Solutions | 1 | 2016 | 43 | 0.530 |
Why?
|
| Term Birth | 2 | 2021 | 140 | 0.530 |
Why?
|
| Extraembryonic Membranes | 1 | 2015 | 37 | 0.510 |
Why?
|
| Hospitals | 7 | 2021 | 3886 | 0.500 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2016 | 111 | 0.490 |
Why?
|
| Trial of Labor | 4 | 2022 | 85 | 0.480 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 150 | 0.480 |
Why?
|
| Stillbirth | 2 | 2015 | 381 | 0.470 |
Why?
|
| Patient Readmission | 3 | 2018 | 3288 | 0.460 |
Why?
|
| Puerperal Disorders | 1 | 2016 | 304 | 0.430 |
Why?
|
| Fee-for-Service Plans | 1 | 2017 | 713 | 0.400 |
Why?
|
| Fluid Therapy | 1 | 2016 | 587 | 0.400 |
Why?
|
| Patient Transfer | 1 | 2019 | 792 | 0.390 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 412 | 0.390 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2017 | 1772 | 0.380 |
Why?
|
| Head | 1 | 2017 | 926 | 0.380 |
Why?
|
| Appointments and Schedules | 1 | 2015 | 443 | 0.380 |
Why?
|
| Physicians | 2 | 2021 | 4598 | 0.360 |
Why?
|
| Uterine Contraction | 3 | 2020 | 91 | 0.350 |
Why?
|
| Education, Medical, Continuing | 2 | 2017 | 829 | 0.350 |
Why?
|
| Program Evaluation | 1 | 2018 | 2507 | 0.330 |
Why?
|
| Military Personnel | 3 | 2017 | 1261 | 0.330 |
Why?
|
| Gynecology | 2 | 2016 | 534 | 0.330 |
Why?
|
| Female | 61 | 2023 | 397187 | 0.330 |
Why?
|
| Surgical Instruments | 1 | 2012 | 381 | 0.320 |
Why?
|
| Chromosome Disorders | 1 | 2011 | 498 | 0.310 |
Why?
|
| Fetus | 2 | 2017 | 1883 | 0.310 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 472 | 0.310 |
Why?
|
| Postpartum Hemorrhage | 3 | 2022 | 275 | 0.310 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1765 | 0.300 |
Why?
|
| Certification | 1 | 2011 | 420 | 0.290 |
Why?
|
| Adult | 38 | 2022 | 223646 | 0.280 |
Why?
|
| Pregnancy Trimester, First | 1 | 2011 | 917 | 0.280 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2018 | 65 | 0.280 |
Why?
|
| Women's Health | 1 | 2016 | 2082 | 0.270 |
Why?
|
| Parity | 5 | 2018 | 931 | 0.270 |
Why?
|
| Twins | 2 | 2018 | 341 | 0.270 |
Why?
|
| Quality Improvement | 2 | 2019 | 3857 | 0.260 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 3490 | 0.260 |
Why?
|
| Research Design | 2 | 2018 | 6209 | 0.250 |
Why?
|
| Placenta | 3 | 2020 | 1725 | 0.250 |
Why?
|
| Postnatal Care | 2 | 2018 | 273 | 0.250 |
Why?
|
| Insurance, Health | 1 | 2017 | 2517 | 0.240 |
Why?
|
| Humans | 65 | 2023 | 768171 | 0.240 |
Why?
|
| Hysterectomy | 2 | 2022 | 863 | 0.230 |
Why?
|
| Lactates | 1 | 2004 | 401 | 0.220 |
Why?
|
| Nifedipine | 1 | 2023 | 220 | 0.210 |
Why?
|
| Hyperoxia | 3 | 2019 | 261 | 0.200 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3837 | 0.200 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2004 | 292 | 0.200 |
Why?
|
| Pregnancy, High-Risk | 2 | 2020 | 121 | 0.200 |
Why?
|
| Fetal Viability | 1 | 2002 | 23 | 0.200 |
Why?
|
| Oxygen | 3 | 2019 | 4270 | 0.200 |
Why?
|
| Young Adult | 13 | 2022 | 60066 | 0.200 |
Why?
|
| Perinatology | 1 | 2002 | 64 | 0.190 |
Why?
|
| Prenatal Care | 3 | 2020 | 1162 | 0.190 |
Why?
|
| Morbidity | 4 | 2021 | 1755 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 4055 | 0.190 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 2176 | 0.190 |
Why?
|
| Logistic Models | 10 | 2020 | 13290 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2018 | 22290 | 0.180 |
Why?
|
| Clinical Competence | 1 | 2017 | 4858 | 0.180 |
Why?
|
| Oxytocics | 1 | 2021 | 67 | 0.180 |
Why?
|
| United States | 16 | 2021 | 73039 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7454 | 0.180 |
Why?
|
| Comorbidity | 3 | 2020 | 10590 | 0.170 |
Why?
|
| Boston | 6 | 2020 | 9374 | 0.170 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2019 | 587 | 0.160 |
Why?
|
| Labor Stage, First | 1 | 2019 | 20 | 0.160 |
Why?
|
| Labor Onset | 1 | 2019 | 17 | 0.160 |
Why?
|
| Regional Health Planning | 1 | 2019 | 95 | 0.160 |
Why?
|
| Florida | 2 | 2018 | 417 | 0.150 |
Why?
|
| Retrospective Studies | 17 | 2021 | 81760 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2021 | 2185 | 0.150 |
Why?
|
| Anesthesia, Spinal | 2 | 2017 | 282 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4064 | 0.150 |
Why?
|
| Placenta Diseases | 1 | 2020 | 199 | 0.150 |
Why?
|
| Estrogen Antagonists | 1 | 2018 | 151 | 0.140 |
Why?
|
| Chorioamnionitis | 1 | 2018 | 156 | 0.140 |
Why?
|
| New York | 2 | 2018 | 882 | 0.140 |
Why?
|
| Patient Positioning | 1 | 2020 | 332 | 0.140 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 359 | 0.140 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 216 | 0.140 |
Why?
|
| Placental Insufficiency | 1 | 2017 | 50 | 0.140 |
Why?
|
| Uterus | 1 | 2021 | 663 | 0.140 |
Why?
|
| Lacerations | 1 | 2018 | 150 | 0.140 |
Why?
|
| Oxytocin | 1 | 2021 | 404 | 0.140 |
Why?
|
| Infant Mortality | 1 | 2002 | 752 | 0.140 |
Why?
|
| Cervical Length Measurement | 1 | 2016 | 47 | 0.130 |
Why?
|
| Massachusetts | 3 | 2021 | 8890 | 0.130 |
Why?
|
| Multivariate Analysis | 5 | 2018 | 12077 | 0.130 |
Why?
|
| Maternal Age | 3 | 2020 | 805 | 0.130 |
Why?
|
| Prostaglandins | 1 | 2017 | 398 | 0.130 |
Why?
|
| Hypothermia, Induced | 1 | 2021 | 754 | 0.130 |
Why?
|
| Epidural Space | 1 | 2017 | 123 | 0.130 |
Why?
|
| Infant, Newborn | 9 | 2022 | 26421 | 0.130 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 587 | 0.130 |
Why?
|
| California | 2 | 2018 | 1438 | 0.130 |
Why?
|
| Catheterization | 1 | 2021 | 1430 | 0.130 |
Why?
|
| Diagnosis-Related Groups | 1 | 2017 | 445 | 0.130 |
Why?
|
| Hypokalemia | 1 | 2016 | 152 | 0.120 |
Why?
|
| Pregnancy, Ectopic | 1 | 2016 | 145 | 0.120 |
Why?
|
| Analgesia, Obstetrical | 1 | 2017 | 169 | 0.120 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2017 | 263 | 0.120 |
Why?
|
| Risk Assessment | 7 | 2019 | 24318 | 0.120 |
Why?
|
| Spinal Puncture | 1 | 2017 | 286 | 0.120 |
Why?
|
| Dehydration | 1 | 2016 | 216 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 3782 | 0.120 |
Why?
|
| Intention | 1 | 2017 | 347 | 0.110 |
Why?
|
| Analgesia, Epidural | 1 | 2017 | 332 | 0.110 |
Why?
|
| Melatonin | 1 | 2019 | 670 | 0.110 |
Why?
|
| Prospective Studies | 6 | 2021 | 54924 | 0.110 |
Why?
|
| Organizational Policy | 1 | 2015 | 435 | 0.110 |
Why?
|
| Version, Fetal | 2 | 2003 | 22 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2019 | 1309 | 0.100 |
Why?
|
| Epilepsy | 1 | 2008 | 3326 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2002 | 2123 | 0.100 |
Why?
|
| Safety | 1 | 2016 | 1159 | 0.100 |
Why?
|
| Risk Adjustment | 1 | 2015 | 599 | 0.090 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2011 | 59 | 0.090 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 3415 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 36741 | 0.090 |
Why?
|
| Cervical Ripening | 2 | 2021 | 18 | 0.090 |
Why?
|
| Linear Models | 2 | 2017 | 5884 | 0.090 |
Why?
|
| Travel | 1 | 2016 | 805 | 0.090 |
Why?
|
| Fetal Development | 1 | 2016 | 779 | 0.090 |
Why?
|
| Puerto Rico | 1 | 2011 | 380 | 0.080 |
Why?
|
| Perinatal Mortality | 1 | 2010 | 103 | 0.080 |
Why?
|
| Middle Aged | 8 | 2021 | 223487 | 0.080 |
Why?
|
| Databases, Factual | 4 | 2019 | 8080 | 0.080 |
Why?
|
| Fetofetal Transfusion | 1 | 2010 | 117 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2271 | 0.080 |
Why?
|
| Obstetric Labor, Premature | 1 | 2010 | 268 | 0.080 |
Why?
|
| Workload | 1 | 2014 | 849 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2016 | 1096 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2020 | 12466 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2019 | 3583 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 2010 | 447 | 0.080 |
Why?
|
| Laparoscopy | 2 | 2017 | 2041 | 0.070 |
Why?
|
| Aneuploidy | 1 | 2011 | 573 | 0.070 |
Why?
|
| Maternal Mortality | 1 | 2010 | 310 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2023 | 65379 | 0.070 |
Why?
|
| Hypertension | 2 | 2023 | 8616 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2017 | 6004 | 0.060 |
Why?
|
| Quality of Health Care | 2 | 2018 | 4310 | 0.060 |
Why?
|
| Canada | 1 | 2011 | 2130 | 0.060 |
Why?
|
| Premature Birth | 1 | 2018 | 1829 | 0.060 |
Why?
|
| Mass Screening | 1 | 2020 | 5458 | 0.060 |
Why?
|
| Odds Ratio | 4 | 2017 | 9669 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 13013 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3573 | 0.060 |
Why?
|
| Obstetrical Forceps | 1 | 2003 | 9 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2011 | 919 | 0.050 |
Why?
|
| Health Policy | 1 | 2015 | 2697 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2020 | 13053 | 0.050 |
Why?
|
| Fetal Death | 1 | 2004 | 434 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
| Breech Presentation | 1 | 2002 | 40 | 0.050 |
Why?
|
| Enalapril | 1 | 2023 | 317 | 0.050 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 26379 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5367 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15949 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15453 | 0.050 |
Why?
|
| Risk Factors | 6 | 2019 | 74944 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2016 | 4543 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2004 | 592 | 0.040 |
Why?
|
| Incidence | 3 | 2018 | 21538 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 9016 | 0.040 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2002 | 235 | 0.040 |
Why?
|
| Receptors, Melatonin | 1 | 2019 | 31 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2020 | 136 | 0.040 |
Why?
|
| Adolescent | 4 | 2021 | 89169 | 0.040 |
Why?
|
| Episiotomy | 1 | 2018 | 21 | 0.040 |
Why?
|
| Extraction, Obstetrical | 1 | 2018 | 28 | 0.040 |
Why?
|
| Pregnancy in Diabetics | 1 | 2020 | 198 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2012 | 8741 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 10397 | 0.040 |
Why?
|
| Catheters | 1 | 2021 | 427 | 0.040 |
Why?
|
| Uterine Rupture | 1 | 2018 | 67 | 0.040 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2017 | 28 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2004 | 1275 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 6525 | 0.040 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2017 | 30 | 0.030 |
Why?
|
| Steroids | 1 | 2002 | 938 | 0.030 |
Why?
|
| Narcotics | 1 | 2018 | 332 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2021 | 2486 | 0.030 |
Why?
|
| Uterine Hemorrhage | 1 | 2018 | 236 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 7852 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2018 | 41753 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2019 | 890 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 12543 | 0.030 |
Why?
|
| Nerve Block | 1 | 2002 | 716 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2021 | 1361 | 0.030 |
Why?
|
| Laparotomy | 1 | 2016 | 458 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 13091 | 0.030 |
Why?
|
| Male | 4 | 2017 | 364731 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2029 | 0.030 |
Why?
|
| Anesthetics, Intravenous | 1 | 2017 | 397 | 0.030 |
Why?
|
| Time Factors | 3 | 2021 | 40220 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 737 | 0.030 |
Why?
|
| Bupivacaine | 1 | 2017 | 414 | 0.030 |
Why?
|
| Fentanyl | 1 | 2017 | 451 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15869 | 0.030 |
Why?
|
| Motion | 1 | 2017 | 790 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 2267 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2018 | 957 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2018 | 2661 | 0.020 |
Why?
|
| Malpractice | 1 | 2015 | 561 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 20225 | 0.020 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 1263 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2017 | 1005 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 1489 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3211 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14729 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 36535 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8542 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2014 | 2923 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5315 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 2593 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2017 | 1946 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8509 | 0.020 |
Why?
|
| Terminal Care | 1 | 2015 | 1770 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 171502 | 0.010 |
Why?
|
| Tocolysis | 1 | 2002 | 18 | 0.010 |
Why?
|
| Software | 1 | 2017 | 4480 | 0.010 |
Why?
|
| Liver | 1 | 2017 | 7578 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 2002 | 332 | 0.010 |
Why?
|
| Prognosis | 1 | 2002 | 30009 | 0.010 |
Why?
|
| Hospitalization | 1 | 2021 | 10840 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 14783 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8747 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 5520 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2002 | 990 | 0.010 |
Why?
|
| Medicare | 1 | 2015 | 6809 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 23648 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39354 | 0.010 |
Why?
|
| Brain | 1 | 2017 | 27362 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 169285 | 0.000 |
Why?
|